- Home
- FWONA vs LH Comparison
FWONA vs LH Comparison
Compare FWONA & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWONA | LH |
|---|---|---|
| Founded | 1950 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Broadcasting | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 21.7B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | FWONA | LH |
|---|---|---|
| Price | $80.80 | $253.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $101.75 | ★ $311.33 |
| AVG Volume (30 Days) | 102.2K | ★ 606.2K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 3.35 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | $24.56 | $8.26 |
| Revenue Next Year | $5.52 | $4.81 |
| P/E Ratio | $97.75 | ★ $24.14 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $73.70 | $239.75 |
| 52 Week High | $99.49 | $293.72 |
Technical Indicators
Market Signals| Indicator | FWONA | LH |
|---|---|---|
| Relative Strength Index (RSI) | 50.63 | 34.80 |
| Support Level | $75.29 | $246.08 |
| Resistance Level | $81.04 | $275.06 |
| Average True Range (ATR) | 1.88 | 7.27 |
| MACD | -0.19 | -1.42 |
| Stochastic Oscillator | 45.74 | 16.52 |
Price Performance
Historical ComparisonAbout FWONA Liberty Media Corporation Series A Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.